EnQuest (LSE: ENQ) full-year 2025 results: Production up 5.4%, dividend raised as South East Asia pivot reshapes growth outlook
Can Southland Holdings, Inc. turn water and data center demand into a cleaner growth story? (NYSE American: SLND)
Read More 6 minute read Pharma Industry News Rubicon Research IPO: Can General Atlantic’s Rs 1,377cr exit test pharma market appetite? Rubicon Research’s ₹1,377 crore IPO opens Oct 9. Backed by General Atlantic, can this pharma play sustain growth and deliver listing gains? byPallavi MadhirajuOctober 3, 2025